Literature DB >> 17945153

Cognitive impairment in amyotrophic lateral sclerosis.

Julie Phukan1, Niall P Pender, Orla Hardiman.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration.

Entities:  

Mesh:

Year:  2007        PMID: 17945153     DOI: 10.1016/S1474-4422(07)70265-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  182 in total

1.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

2.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

3.  Right hemisphere dysfunction and emotional processing in ALS: an fMRI study.

Authors:  A Palmieri; M Naccarato; S Abrahams; M Bonato; C D'Ascenzo; S Balestreri; V Cima; G Querin; R Dal Borgo; L Barachino; C Volpato; C Semenza; E Pegoraro; C Angelini; G Sorarù
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

4.  Diffusion tensor tract-specific analysis of the uncinate fasciculus in patients with amyotrophic lateral sclerosis.

Authors:  Kanako Sato; Shigeki Aoki; Nobue K Iwata; Yoshitaka Masutani; Takeyuki Watadani; Yasuhiro Nakata; Mariko Yoshida; Yasuo Terao; Osamu Abe; Kuni Ohtomo; Shoji Tsuji
Journal:  Neuroradiology       Date:  2010-02-20       Impact factor: 2.804

5.  Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.

Authors:  Alessandra Gaiani; Ilaria Martinelli; Luca Bello; Giorgia Querin; Marco Puthenparampil; Susanna Ruggero; Elisabetta Toffanin; Annachiara Cagnin; Chiara Briani; Elena Pegoraro; Gianni Sorarù
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

6.  Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited.

Authors:  Caroline A Sage; Wim Van Hecke; Ronald Peeters; Jan Sijbers; Wim Robberecht; Paul Parizel; Guy Marchal; Alexander Leemans; Stefan Sunaert
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

7.  Rule violation errors are associated with right lateral prefrontal cortex atrophy in neurodegenerative disease.

Authors:  Katherine L Possin; Simona M Brambati; Howard J Rosen; Julene K Johnson; Judy Pa; Michael W Weiner; Bruce L Miller; Joel H Kramer
Journal:  J Int Neuropsychol Soc       Date:  2009-05       Impact factor: 2.892

8.  Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis.

Authors:  Takao Nomura; Shoji Watanabe; Kumi Kaneko; Koji Yamanaka; Nobuyuki Nukina; Yoshiaki Furukawa
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

9.  Amyotrophic lateral sclerosis affects cortical and subcortical activity underlying motor inhibition and action monitoring.

Authors:  Bahram Mohammadi; Katja Kollewe; David M Cole; Anja Fellbrich; Marcus Heldmann; Amir Samii; Reinhard Dengler; Susanne Petri; Thomas F Münte; Ulrike M Krämer
Journal:  Hum Brain Mapp       Date:  2015-04-24       Impact factor: 5.038

10.  Survival profiles of patients with frontotemporal dementia and motor neuron disease.

Authors:  William T Hu; Harro Seelaar; Keith A Josephs; David S Knopman; Bradley F Boeve; Eric J Sorenson; Leo McCluskey; Lauren Elman; Helenius J Schelhaas; Joseph E Parisi; Benno Kuesters; Virginia M-Y Lee; John Q Trojanowski; Ronald C Petersen; John C van Swieten; Murray Grossman
Journal:  Arch Neurol       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.